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an Adapter Protein that Regulates Early
TCR-Initiated Signaling in Th2 Lineage Cells
garding earlier, TCR-proximal signaling events that are
unique to these subsets.
Here we report the isolation of a TCR-regulated pro-
tein that plays a role in signaling events leading to Th2
development and/or activation, which we named SWAP-
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La Jolla Institute for Allergy and Immunology 70-like adapter of T cells (SLAT) based on its selective
expression in T cells and its homology with SWAP-70,10355 Science Center Drive
San Diego, California 92121 a B cell-enriched protein that functions as a scaffolding
component of the Ig DNA recombination complex in B
lymphocytes (Borggrefe et al., 1998). SLAT is selectively
upregulated in Th2 cells, translocates to the immunolog-Summary
ical synapse (IS) upon antigen stimulation, and has op-
posite effects on IL-4 versus IFN production in retrovi-We describe the isolation of a protein, SWAP-70-like
adapter of T cells (SLAT), which is expressed at high rus-transduced T cells. We provide additional evidence
that SLAT may mediate this regulatory activity via itslevels in thymocytes and differentiated Th2 cells. SLAT
expression was upregulated in differentiating Th2 cells association with the ZAP-70 kinase and inhibition of its
function.and downregulated in Th1 cells. Ectopic SLAT expres-
sion exerted positive or negative effects on IL-4 versus
IFN induction, respectively. TCR signaling induced Results
translocation of SLAT to the immunological synapse
and its association with ZAP-70 kinase. SLAT reduced Isolation and Structure of SLAT
the association of ZAP-70 with TCR- and interfered To identify Th2-specific genes, we performed a differen-
with ZAP-70 but not Lck signaling. Consistent with tial display analysis (Liang and Pardee, 1992) on cDNA
these results, pharmacological inhibition of ZAP-70 libraries from in vitro-differentiated Th1 and Th2 cells
also induced Th2 skewing. Thus, SLAT is a protein derived from AD10 TCR-transgenic mice. Several differ-
which plays a role in Th2 development and/or activa- entially expressed cDNAs were revealed, the most
tion, perhaps by interfering with ZAP-70 signaling. prominent of which was selectively expressed in Th2
but not Th1 cells (Figure 1A). Sequencing revealed a
Introduction sequence of 1003 nucleotides, termed Cl-45, with mini-
mal homology to known sequences. This cDNA frag-
T helper (Th) cells play a central role in the immune ment hybridized to a 1.8 kb transcript, which was se-
response. Antigen-stimulated CD4 Th0 cells differenti- lectively expressed in Th2 cells (Figure 1B).
ate into Th1 or Th2 cells, which are associated with Using a Th2 cDNA library, rapid amplification of cDNA
discrete cytokine production profiles in both mice and ends (RACE) was used to obtain a complete reading
humans (Del Prete et al., 1991; Mosmann et al., 1986). frame included within a cDNA sequence of 2217 nucleo-
In addition to T cell receptor (TCR) signals, the differenti- tides. The partial cDNA (Cl-45) corresponds to nucleo-
ation and maintenance of Th1/Th2 subsets is regulated tides 1211–2217 of this sequence. Nucleotides 1–1893
by cytokines and costimulatory signals (Abbas et al., contain a complete reading frame, which encodes a
1996; Murphy et al., 2000; O’Garra and Murphy, 1994). putative protein of 630 amino acids (Figure 2A). Compar-
Progress was recently made in characterization of tran- ison with the NCBI GenBank database yielded signifi-
scription factors that dictate the development of Th1 cant amino acid homology (45%) with mouse SWAP-70
or Th2 subsets (Dong and Flavell, 2001; Glimcher and (Figure 2B) (Borggrefe et al., 1998). Furthermore, the
Murphy, 2000; Murphy et al., 2000). While Th2 develop- domain structure of the putative protein is similar to
ment is associated with the expression of GATA-3 (Fer- that of SWAP-70. Thus, we named this cDNA SLAT, for
ber et al., 1999; Ouyang et al., 1998; Zhang et al., 1997, SWAP-70 like adapter of T cells. The predicted amino
1999; Zheng and Flavell, 1997) and c-Maf (Ho et al., acid sequence contains a potential Ca2 binding EF
1996, 1998; Kim et al., 1999), T-bet plays a central role hand, an imperfect ITAM-like motif, a pleckstrin-homol-
in Th1 development (Szabo et al., 2000). Earlier studies ogy (PH) domain, a potential nuclear localization signal
described differences between Th1 and Th2 cells in (NLS), and an ezrin-radixin-moesin (ERM)-homology do-
TCR-induced protein tyrosine kinase (PTK) activation, main (Figure 2C).
tyrosine phosphorylation profiles, and Ca2 signaling
(Fitch et al., 1993; Gajewski et al., 1990; Tamura et al., Expression of SLAT
1993, 1995), but the basis of these differences has not To examine SLAT protein expression, we generated a
been elucidated. More recent studies pointed to the polyclonal rabbit antiserum. The specificity of this anti-
importance of mitogen-activated protein kinases body was confirmed by demonstrating that it immuno-
(MAPKs) in Th1/Th2 differentiation and cytokine produc- precipitated a 75 kDa protein from SLAT-transfected
tion (Dong et al., 2001), but little information exists re- but not from empty vector-transfected 293T cells (data
not shown). This antiserum recognized a protein of 75
kDa, which was present in peripheral blood T cells and*Correspondence: amnon@liai.org
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confocal analysis (Figure 3E). SLAT was mostly localized
in the membrane of T cells with a much fainter cyto-
plasmic expression. It was much more abundant in Th2
cells than in naive or Th1 cells. Parallel staining with an
anti-TCR antibody revealed similar levels of predomi-
nantly membrane expression of TCR in all three T cell
types. More importantly, merging of the SLAT and TCR
images indicates a more intense colocalization of SLAT
with TCR in Th2 cells by comparison with naive or Th1
cells. This colocalization is also consistent with results
shown later (Figure 4).
Next, we analyzed the expression of SLAT in different
cell lines or mouse tissues. SLAT was expressed in puri-
fied human peripheral blood T cells, an established Th2
clone, Jurkat T cells, and THP-1 cells; however, very
little or no expression was observed in a Th1 clone, EL4
thymoma, a B cell lymphoma, or a mast cell line (Figure
3F). Similar analysis of fresh murine organs or tissues
revealed abundant SLAT expression in the thymus but
not in other organs or cells (Figure 3G). However, longer
development of the same membrane also revealed SLATFigure 1. Isolation of a Partial Th2-Specific cDNA (Cl-45)
expression in the spleen and lymph nodes (data not(A) Differential display analysis. mRNAs were isolated from in vitro-
differentiated Th2 and Th1 cells on day 4 were amplified by RT- shown). Similar results were obtained in multitissue
PCR. cDNA populations were analyzed on a 6% sequencing gel. Northern blot analysis (data not shown).
(B) Expression of SLAT mRNA. mRNAs isolated from in vitro-differ-
entiated Th1 or Th2 populations as in (A) were hybridized with SLAT
(left) or G3PDH (right) probes and analyzed by Northern blotting.
Antigen-Induced Translocation of SLAT
to the Immunological Synapse
The membrane localization of SLAT in Th2 cells (Figurethymocytes but not in nonlymphoid cells (Figures 3F
3D) and the apparent regulation of its expression byand 3G and data not shown).
TCR signals (Figure 3C) led us to examine the effect ofSLAT was detectable in fresh primary T cells. Its level
antigen stimulation on the intracellular localization ofincreased after 4 days of culture under Th2-polarizing
SLAT in peptide-stimulated differentiated AD10 Th2conditions but not in Th1-polarized cells (Figure 3A). RT-
cells (Figure 4). In unstimulated Th2 cells, SLAT wasPCR analysis revealed that mRNAs for IFN or IL-4 were
fairly uniformly distributed in the membrane (Figure 4A).induced in the differentiating T cells by day 2 of culture,
Agonist stimulation induced translocation of SLAT tobefore the first detectable increase in SLAT expression
the contact area between the T cells and APCs (Figure(Figure 3B). Therefore, we addressed the possibility that
4E) and its colocalization with TCR (Figure 4F). TCRSLAT expression is induced by Th2-specific cytokines,
was also concentrated, albeit not exclusively localized,which are produced earlier in response to TCR and/or
at the IS (Figure 4D). Further analysis of SLAT localiza-costimulatory signals, by testing the effect of IL-4-, IL-
tion vis-a`-vis that of talin revealed localization of both12-, and IFN-neutralizing antibodies on SLAT expres-
proteins to the IS in agonist-stimulated Th2 cells (Figuression. Because these antibodies prevented polarization
4J and 4K). However, SLAT was also localized in theof naive T cells into Th1 or Th2 populations, we used
central area of the IS where talin was not detectable,them in secondary, antigen-restimulated cultures (Fig-
i.e., the cSMAC (Figure 4L). Thus, agonist stimulationure 3C). Prior to restimulation (d0), both Th2 and Th1
induces translocation of SLAT to the IS, where it is foundcells expressed relatively low and similar levels of SLAT.
both in the pSMAC and cSMAC. A similar localizationRestimulation caused a substantial increase in SLAT
of PKC, which is not restricted to either the cSMAC orexpression on day 2 and especially on day 5 in Th2 but
pSMAC, was recently observed in T cells stimulatednot in Th1 cells (Figure 3C). Importantly, the neutralizing
by TCR ligation in the absence of CD28 costimulationantibodies did not prevent the upregulation of SLAT in
(Huang et al., 2002).Th2 cells, nor did they affect its basal expression in Th1
We also analyzed the effect of an antagonistic alteredcells. These results indicate that IL-4, IL-12, and IFN
peptide ligand (APL) on SLAT localization. The APL failedare not required for upregulation of SLAT expression.
to induce substantial TCR or PKC translocation to theRather, the observed increase in SLAT expression in
IS (data not shown) but caused SLAT to translocate toTh2 cells occurs, most likely, in response to initial TCR
the T cell-APC contact area (Figures 4G–4I). However,(and/or costimulatory) signals.
the localization of SLAT in the contact area appearedThe presence of a potential plasma membrane-tar-
to be less focused than in agonist-stimulated Th2 cellsgeting pH domain in SLAT led us to examine SLAT ex-
(compare Figures 4E versus 4H), and SLAT-TCR colo-pression in T cell membranes. Membranes of unstimu-
calization was minimal (Figure 4I). The ability of the APLlated or 2 day-stimulated CD4 cells contained very
to induce an incomplete synapse between the T cellslow levels of SLAT (Figure 3D). SLAT was consistently
and APCs is consistent with our recent finding (Huangupregulated after 4 days of culture in the differentiated
Th2 but not Th1 cells. This difference was confirmed by et al., 2000).
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Figure 2. Sequence and Domain Structure of SLAT
(A) Nucleotide and deduced amino acid sequence of murine SLAT. The EF hand, the ITAM-like motif, the pH domain, the nuclear localization
signal (NLS), and the ERM domain are underlined and indicated by the numbers 1–5, respectively, shown along the deduced amino acid
sequence.
(B) Comparison of the deduced amino acid sequence of murine SLAT and SWAP-70. Identical amino acids are boxed in black.
(C) Domain structure of SLAT. Numbers above the scheme refer to amino acid residues.
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Figure 3. Selective Expression of SLAT in Th2 Lineage Cells
(A) SLAT protein expression in primary T cells. Naive CD4 AD10 T cells were differentiated under Th2- or Th1-inducing conditions, and lysates
prepared at the indicated time points after stimulation were analyzed by immunoblotting as indicated. The data shown are representative of
three independent experiments.
(B) Expression of SLAT and cytokine mRNA. AD10 T cells were differentiated as in (A) and the expression of mRNA for SLAT, IFN, IL-4, or
actin was analyzed by a semiquantitative RT-PCR on the indicated days.
(C) Effect of cytokine-neutralizing antibodies on SLAT expression. Naive AD10 T cells differentiated under Th2- or Th1-inducing conditions
were restimulated on day 7 with PCC peptide plus APCs in the absence or presence of neutralizing anti-IL-4, -IL-12, and -IFN antibodies
(10g/ml each). Lysates prepared at different time points were immunoblotted as in (A). The data shown are representative of three independent
experiments.
(D) SLAT membrane expression. Membrane fractions were prepared at the indicated times from naive AD10 T cells differentiated under Th2-
or Th1-inducing conditions, and analyzed by anti-SLAT or anti-actin immunoblotting. Numbers under the SLAT blot indicate relative intensity
of the SLAT signal, normalized to the actin expression level. The data are representative of three independent experiments.
(E) Confocal analysis of SLAT localization in T cells. AD10 naive T cells or 14 day-differentiated Th1 or Th2 cells were fixed and permeabilized,
and SLAT (green) or TCR (red) were visualized by anti-SLAT or anti-TCR antibody staining and immunofluorescence microscopy.
(F) SLAT protein expression in cell lines. Extracts from human purified T cells, TCR/KAE (Th2 cell clone), AD10 (Th1 cell clone), Jurkat (T cell
lymphoma), EL4 (thymoma), CH27 (B cell lymphoma), MCP-5 (mast cell line), or THP-1 (macrophage cell line) were analyzed by immunoblotting
with an anti-SLAT antiserum (top) or with an actin-specific antibody (bottom).
(G) Tissue distribution of SLAT protein. Cellular extracts from the indicated fresh mouse tissues and organs were analyzed as in (F).
SLAT Regulates IL-4 and IFN Expression periment (Figure 5C), transduction of primary T cells
with SLAT reduced the fraction of IFN-producing cellsTo determine whether SLAT regulates the production of
Th1 and/or Th2 cytokines, we initially studied its effect in the GFP population from49% to 34% (30% inhibi-
tion). In contrast, the fraction of IFN-producing cells inon the activity of IL-4 or IFN promoter-luciferase (Luc)
reporter genes in Jurkat T cells. Compared to the empty the nontransduced cells was not decreased and, in fact,
slightly increased (from28% to33%; left quadrants).vector-transfected cells, SLAT overexpression in-
creased both the basal and anti-CD3-induced activity In four separate experiments, SLAT expression reduced
the fraction of GFP IFN-producing cells from 46.5%of the IL-4-Luc reporter gene, and conversely, it reduced
the activity of the IFN-Luc gene (Figure 5A). Immu- 1.3% to 37.8%  4.0% (p  0.01 by Student’s t test).
We could not assess the effects of SLAT on IL-4-noblot analysis confirmed the overexpression of SLAT
in the transfected cells (Figure 5A, inset). producing cells in primary nonpolarized cultures,
since1% of the cells produced IL-4 under these condi-Next, we generated a retroviral SLAT expression vec-
tor (Figure 5B), which was used to infect anti-CD3/CD28- tions (data not shown). Therefore, we assessed the ef-
fect of retroviral SLAT transduction in restimulated Th2stimulated, nonpolarized AD10 CD4 T cells. Under
these conditions, a transduction efficiency of 40%–50% cells. Analysis of GFP IL-4-producing cells revealed a
SLAT-induced increase of 24% in IL-4-producing cellswas achieved (data not shown). In a representative ex-
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SLAT in TCR signaling by attempting to identify SLAT-
associated tyrosine-phosphorylated proteins.
SLAT immunoprecipitates from antigen-stimulated
polarized Th2 cells contained a few tyrosine-phosphory-
lated proteins of 62, 70, and 98 kDa (data not
shown); however, no phosphotyrosine (pTyr)-containing
protein with a size corresponding to SLAT was detected
(see Figure 6D), suggesting that SLAT itself is not phos-
phorylated. We identified the 70 kDa protein as ZAP-
70. Endogenous ZAP-70 from unstimulated Jurkat cells
was associated with a very low level of transfected
SLAT, a level that was not increased by phorbol ester
plus Ca2 ionophore stimulation; however, anti-CD3
stimulation increased the amount of ZAP-70-associated
SLAT (Figure 6A). Similarly, endogenous ZAP-70 from
antigen-stimulated Th2 cells also coimmunoprecipi-
tated with SLAT (Figure 6B). In preliminary experiments
we found that SLAT is not phosphorylated on tyrosine
and, furthermore, that the ITAM-like motif of SLAT (Fig-
ure 2C) does not seem to be required for its association
(data not shown).
SLAT Selectively Inhibits
ZAP-70-Dependent Signaling
The inducible association of SLAT with ZAP-70 led us to
examine whether SLAT modulates ZAP-70-dependent
functions. Since T cell activation requires Lck-induced
tyrosine phosphorylation of TCR- chain and subse-
quent recruitment of ZAP-70 to phospho- (Chan et al.,
1992; Chu et al., 1998; Iwashima et al., 1994; Madrenas
et al., 1995; Sloan-Lancaster et al., 1994), we assessedFigure 4. Antigen-Induced SLAT Translocation to the IS
the effect of SLAT on these events (Figure 6C). To facili-In vitro-differentiated AD10 TCR-transgenic Th2 cells were incu-
tate the detection of SLAT:ZAP-70 complexes, the cellsbated for 30 min with CH27 cells that were either nonpulsed (A–C)
were also cotransfected with a fixed amount of ZAP-or pulsed with PCC agonist (D–F and J–L) or antagonist (G–I) peptide.
Cells were processed for TCR (red [A, D, and G]) plus SLAT (green 70 DNA. Increasing amounts of ZAP-70 were found to
[B, E, and H]), or SLAT (red [J]) plus talin (green [K]). Overlay of the associate with immunoprecipitated SLAT in a dose-
red and green images is shown in the right column (C, F, I, and L). dependent manner; furthermore,  was not detectable
in the SLAT immunoprecipitates (left four lanes). In con-
trast, the association of ZAP-70 with immunoprecipi-
in a representative experiment (Figure 5D). This increase tated was reduced and inversely related to the expres-
sion of SLAT (right four lanes), and no SLAT waswas even more pronounced when comparing the frac-
detectable in the  immunoprecipitates. These resultstion of IL-4-producing cells among the SLAT-infected,
indicate that SLAT decreases the amount of TCR--GFP cells (72.8%) to that in the noninfected (GFP	)
associated ZAP-70 in activated T cells and, furthermore,population (39.8%). In six independent experiments, this
that ZAP-70:SLAT and ZAP-70:TCR- complexes areincrease averaged 22% (p  0.001). We also examined
mutually exclusive, supporting the notion that SLATthe effect of SLAT transduction on IFN-producing cells
competes with TCR- for ZAP-70 binding.in secondary restimulated Th1 cultures but found no
To determine how the association of SLAT with ZAP-consistent effects (data not shown), suggesting that
70 affects its inducible tyrosine phosphorylation, we alsoSLAT primarily reduces Th1 expansion from naive T cells
assessed the pTyr content of SLAT- versus phospho-but not already differentiated Th1 cells. We conclude
-associated ZAP-70 in similarly transfected cells. Asthat SLAT moderately but consistently reduces the pro-
shown above (Figure 6C), more ZAP-70 was associatedportion of Th1 cells and, conversely, increases the level
with phospho- than with endogenous SLAT, and thisof IL-4-producing cells.
ratio was reversed in SLAT-overexpressing cells (Figure
6D, top panel). While the relative pTyr content of ZAP-
SLAT Interacts with ZAP-70 70 associated with endogenous SLAT and phospho-
The results above argue in favor of a potentially impor- was similar, SLAT overexpression led to a more pro-
tant role of SLAT in TCR signaling events, which regulate nounced loss of pTyr from the phospho--associated
in a reciprocal manner the activation and/or expansion fraction of ZAP-70 (second panel from top). Moreover,
of Th1 and Th2 cells. Early TCR signaling events include the total content of Tyr-319-phosphorylated ZAP-70 was
the formation of signaling complexes composed of en- considerably reduced in SLAT-overexpressing cells
zymes and adaptor proteins, many of which are phos- (Figure 6D, right panels). Thus, increased expression
phorylated on tyrosine (Kane et al., 2000; Rudd, 1999). of SLAT, which occurs in differentiated Th2 cells, is
associated with reduced activation of ZAP-70.Therefore, we began to analyze the potential role of
Immunity
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We further assessed total tyrosine phosphorylation
profiles in SLAT-overexpressing Jurkat cells (Figure 6E).
Anti-CD3 stimulation increased the total pTyr level in
empty vector-transfected cells, and increased SLAT ex-
pression was associated with a dose-dependent de-
crease in the basal or anti-CD3-induced total tyrosine
phosphorylation of some substrates (top panel). How-
ever, this decrease was selective in that SLAT overex-
pression decreased the pTyr content of p16-21, p30-
36, p42, and p70, but not p26 and p56-60.
In order to identify some of the pTyr-containing pro-
teins and further determine whether SLAT overexpres-
sion differentially affects Lck- versus ZAP-70-mediated
phosphorylation events, we assessed the tyrosine phos-
phorylation of immunoprecipitated LAT, which is a direct
substrate of ZAP-70 (Zhang et al., 1998), phospholipase
C-1 (PLC1), whose phosphorylation is ZAP-70 depen-
dent (Williams et al., 1998), or TCR-, an established Lck
substrate (Iwashima et al., 1994) (Figure 6D, bottom five
panels). SLAT reduced the inducible tyrosine phosphor-
ylation of immunoprecipitated LAT in a dose-dependent
manner and also inhibited the phosphorylation of
PLC1, while having no detectable effect on the induc-
ible phosphorylation of TCR-. These results indicate
that the reduction of the ZAP-70: complex by increased
SLAT expression (Figures 6C and 6D) does not result
from decreased TCR- tyrosine phosphorylation. More
important, the intact tyrosine phosphorylation of TCR-
in SLAT-overexpressing cells in the presence of reduced
LAT and PLC1 phosphorylation strongly suggests that
SLAT selectively inhibits ZAP-70- but not Lck-mediated
phosphorylation events.
Pharmacological ZAP-70 Inhibition Induces
Preferential Th2 Differentiation
Next, we wished to determine whether selective inhibi-
tion of ZAP-70 by upregulated SLAT accounts for the
observed effects of SLAT expression on Th1 versus Th2
activation. We evaluated the effects of piceatannol, a
compound that selectively inhibits the activities of ZAP-
70 and Syk (Oliver et al., 1994; Soede et al., 1998), on
Th differentiation. Piceatannol (2.5 g/ml) reduced by
50% the fraction of IFN-producing cells in stimulated
naive T cells cultured under Th1-inducing conditions
(Figure 7A) and, conversely, increased by 2-fold the frac-
tion of IL-4-producing cells in Th2-differentiated cul-
tures (Figure 7B). Consistent with these results, picea-
tannol treatment reduced IFN secretion by 70% and
Figure 5. Ectopic SLAT Expression Activates the IL-4 Gene and moderately increased (by 37%) the production of IL-4
Inhibits the IFN Gene
(Figures 7C and 7D, respectively). Under the same con-
(A) IL-4 and IFN promoter transactivation. Jurkat-TAg cells were ditions, piceatannol failed to inhibit proliferation of thecotransfected with IL-4 or IFN promoter-reporter plasmids plus a
same cells (Figures 7E and 7F, respectively). The effect-Gal reporter plasmid together with a SLAT expression vector (or
a control empty vector). Two days later, the cells were left unstimu-
lated or stimulated with a crosslinked anti-CD3 antibody (OKT3; 2
g/ml) for 16 hr. Cell extracts were assayed for -Gal-normalized
luciferase activity. Expression levels of transfected SLAT are shown cells were enumerated by ICCS. Data are displayed as two-color
in the inset. The data shown are representative of three independent dot plots showing GFP (horizontal axis) versus intracellular IFN
experiments. (vertical axis) expression. The data shown are representative of four
(B) Schematic diagram of retroviral SLAT constructs in the pMIG independent experiments.
vector. (D) Seven day-differentiated Th2 cells were restimulated with anti-
(C) Naive CD4 T cells were infected with a SLAT-expressing or CD3 plus -CD28 antibodies and infected with the indicated retrovi-
control (GFP) retrovirus after primary activation by anti-CD3 plus ruses. Intracellular IL-4 staining was performed on day 11 (4 days
-CD28 antibodies plus IL-2. Cells were harvested on day 4, restimu- after restimulation) as in (C). The data shown are representative of
lated with anti-CD3 plus -CD28 antibodies, and cytokine-producing six independent experiments.
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Figure 6. SLAT Interacts with ZAP-70 and Selectively Inhibits Its Function
(A) Jurkat-TAg cells transfected with SLAT (10 g) were either left unstimulated or stimulated with PMA plus ionomycin or with crosslinked
anti-CD3 antibody for 5 min. ZAP-70 immunoprecipitates were analyzed by SDS-PAGE and immunoblotting with anti-SLAT (top panel) or anti-
ZAP-70 (middle panel) antibodies. An aliquot of the cell lysates was immunoblotted with anti-SLAT (bottom panel).
(B) Differentiated Th2 cells were stimulated with APCs that were either nonpulsed or pulsed with 3 M PCC peptide. SLAT immunoprecipitates
were immunoblotted with anti-ZAP-70 (top panel) or anti-SLAT (middle panel) antibodies. An aliquot of the cell lysates was immunoblotted
with an anti-ZAP-70 antibody (bottom panel).
(C) Jurkat-TAg cells cotransfected with ZAP-70 (2 g) plus increasing amounts of SLAT (or empty vector) were stimulated for the final 10 min
of a 36 hr culture with crosslinked anti-CD3. SLAT (left right lanes) or TCR- (right four lanes) immunoprecipitates were immunoblotted with
anti-ZAP-70, -Xpress (SLAT), or -TCR- antibodies. Aliquots of cell lysates were also blotted with anti-ZAP-70 (bottom panel). No ZAP-70 was
detected in immunoprecipitates from unstimulated cells (data not shown).
(D) Jurkat-TAg cells were cotransfected and stimulated as in (C). SLAT (left two lanes) or TCR- (right two lanes) immunoprecipitates were
analyzed by immunoblotting with anti-ZAP-70, -pTyr, -Xpress (SLAT), or -TCR- antibodies. Aliquots of cell lysates were blotted with anti-
ZAP-70 or -phospho-ZAP-70 (Tyr-319) antibodies (right panel).
(E) Jurkat-TAg cells cotransfected as in (C) were left unstimulated or stimulated with anti-CD3. Aliquots of cell lysates were immunoblotted
with an anti-pTyr, -HA (ZAP-70), -Xpress (SLAT) or -actin antibodies (top four panels, respectively). LAT, PLC1, or TCR- immunoprecipitates
from the same cells were immunoblotted with anti-pTyr, -LAT, or PLC1 antibodies (five bottom panels). The data shown are representative
of three independent experiments.
of higher piceatannol concentrations could not be evalu- tides (accession number X96705). Since mouse SLAT
and Def-6 display a 92% amino acid homology, we con-ated reliably since they inhibited proliferation, although
they did not appear to be toxic (data not shown). To clude that Def-6 is the human homolog of SLAT. The
study describing a partial murine def-6 sequence, whichconfirm inhibition of cellular ZAP-70 activity by piceatan-
nol, we immunoblotted lysates of cells treated or not corresponds to nucleotides 42–423 of SLAT, did not
report its expression in T cells (Hotfilder et al., 1999).with increasing concentrations of piceatannol with an
antibody specific for phospho-Tyr-319 of ZAP-70, Here, we show that SLAT is expressed in thymocytes
and in differentiated Th2 cells and, in addition, in awhose autophosphorylation is critical for ZAP-70 down-
stream signaling (Di Bartolo et al., 1999; Williams et al., monocyte cell line. The latter expression is consistent
with the original isolation of Def-6 from a differentiating1999). Piceatannol inhibited the autophosphorylation of
Tyr-319 in a dose-dependent manner. myeloid cell line (Hotfilder et al., 1999). Furthermore, we
show that SLAT plays a role in TCR-mediated signal
transduction pathways associated with Th2 differentia-Discussion
tion and/or activation.
Extensive studies addressed the role of cytokine sig-We report the isolation of a mouse SWAP-70 homolog,
termed SLAT. Sequence comparison indicates that nals in Th1 and Th2 development (Abbas et al., 1996;
O’Garra and Murphy, 1994). However, cytokine signalingSLAT is most likely the T cell counterpart of SWAP-70
(Figure 2B). A search of the NCBI GenBank database occurs downstream of the initial regulation of Th1 and
Th2 cells, which must rely on production of IL-4, IFN,subsequently revealed a homologous human cDNA
known as def-6 encoding a putative protein of 631 amino and IL-12 in response to TCR and costimulatory signals
in the first place. Examples of this are findings that Th2acids (accession number NM_022047) and a corre-
sponding mouse partial cDNA sequence of 380 nucleo- cells can be generated in the complete absence of the
Immunity
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Figure 7. Pharmacological Inhibition of ZAP-70 Induces Preferential Th2 Differentiation
Naive AD10 CD4 T cells were differentiated under Th1 (A, C, and E) or Th2 (B, D, and F) -inducing conditions in the absence or presence of
piceatannol (2.5 g/ml). On day 10, the cells were restimulated with anti-CD3 plus -CD28 mAbs. The data shown are representative of three
independent experiments.
(A and B) Cytokine-producing cells were enumerated by ICCS.
(C and D) Levels of IFN or IL-4 in 48 hr stimulated culture supernatants of untreated (empty bars) or piceatannol-treated (black bars) cells
were quantified by an ELISA.
(E and F) Proliferation was determined after 72 hr of stimulation by 3 HTdR uptake in cells labeled for the final 16 hr. All data are expressed
as the mean value of triplicate determinations SE.
(G) Naive CD4 T cells (3 
 106 cells) pretreated with or without piceatannol for 2 hr were stimulated by a crosslinked anti-CD3 antibody for
2 min. Aliquots of cell lysates were immunoblotted with anti-pZAP-70 (Tyr-319) or actin antibodies. Relative densities of the phospho-ZAP-
70 signal normalized to the actin signal are shown.
IL-4R or its signaling intermediate STAT6 (Dent et al., strate (Iwashima et al., 1994). Therefore, TCR and/or
costimulatory signals, rather than cytokines, likely regu-1998; Finkelman et al., 2000; Jankovic et al., 2000), and
that Th1 cells can be generated in the absence of the IL- late SLAT, a conclusion supported by our finding that
neutralization of secreted IL-4, IL-12, and IFN did not12R signaling intermediate STAT4 (Kaplan et al., 1998).
Thus, commitment to Th1 or Th2 differentiation path- have a significant effect on the upregulation of SLAT in
Th2 cells.ways is decided before cytokine receptor signaling oc-
curs, and the latter may serve primarily to amplify the Increased expression of SLAT was first observed in
primary differentiating Th2 cells only after 3–4 days ofnumber of Th1 and Th2 cells.
Several findings indicate that SLAT acts at a proximal culture, and perhaps a little earlier (2 days) in restimu-
lated Th2 cells. Therefore, SLAT does not appear tostep during TCR signaling. First, SLAT resides in the
membrane of naive T cells, and it is recruited to the IS regulate the earliest TCR signaling steps in naive Th0
cells but, rather, does appear to function at a later point,in antigen-stimulated Th2 cells. Second, SLAT inducibly
associates with ZAP-70, a proximal TCR-associated ty- after Th1/Th2 commitment has occurred, to regulate the
differentiation and/or expansion of Th1 and Th2 cells,rosine kinase essential for T cell activation (Chu et al.,
1998). The inability of PMA plus ionomycin treatment to leading to a decrease in the number of the former and
an increase in the number of the latter. Such a role isinduce this association suggests that it is regulated by
proximal TCR signals occurring upstream of Ca2mobili- consistent with our findings that the reduction of IFN-
secreting Th1 cells and the increase of IL-4-producingzation and/or protein kinase C activation. Third, tran-
sient SLAT overexpression inhibited ZAP-70-dependent Th2 cells induced by SLAT retrovirus infection are rela-
tively moderate. A number of possibilities may accounttyrosine phosphorylation of LAT without interfering with
tyrosine phosphorylation of TCR-, a known Lck sub- for the relatively late effects of SLAT. For example, SLAT
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may positively regulate the expression and persistence In summary, our findings indicate that SLAT plays a
of Th2-determining transcription factors such as role in TCR-mediated signal transduction pathways in
GATA-3 or c-Maf, or it may provide a selective growth Th2 differentiation, activation, and/or expansion. Further
or survival signal to developing Th2 cells. work should be aimed at defining the precise mecha-
The inducible association of SLAT with ZAP-70, which nisms that regulate the expression and function of SLAT
may competitively reduce the association of ZAP-70 with in T lymphocytes, including its potential role in T cell
phospho-, provides a potential mechanism for the ability development. Furthermore, the selective effects of SLAT
of SLAT to positively regulate Th2 cells, namely, via inhibi- on Th1 versus Th2 differentiation and cytokine produc-
tion of ZAP-70-dependent signaling, which may reduce tion suggest that SLAT may represent a potential drug
the overall strength of TCR signaling, thereby favoring target for diseases that are characterized by skewing
Th2 development. Such a mechanism is supported by of the Th1/Th2 balance.
several independent observations. First, treatment of
antigen-specific T cells with piceatannol, a ZAP-70 inhibi- Experimental Procedures
tor, reduced Th1 induction and, conversely, enhanced Th2
induction and IL-4 production (Figure 7). Second, in con- Mice and Reagents
B10.A mice were purchased from The Jackson Laboratories. AD10trast to Th1 cells, ZAP-70 is not activated in Th2 cells
TCR-transgenic B10.A mice expressing a TCR specific for PCC pep-(Tamura et al., 1995) and APLs with lower affinity for
tide 88–104 in association with I-Ek (Kaye et al., 1992) were bredthe TCR, which skewed Th differentiation toward a Th2
and maintained in our animal facility. Recombinant IL-2, IL-4, and IL-phenotype, failed to activate ZAP-70 and Fyn (Faith et
12 were purchased from PeproTech. Monoclonal antibodies (mAbs)
al., 1999; Singh et al., 1999). Third, TCR triggering was specific for IL-4 (11B11), IL-12 (C17.8), IFN (H22), and TCR (H57-
found to induce a weaker overall tyrosine phosphoryla- 597) were purchased from Pharmingen. A talin-specific mAb, 8d4,
tion and ZAP-70: association in human Th2 than in was purchased from Sigma. Polyclonal anti-ZAP-70 (LR) and anti-
PKC (C-18) antibodies were from Santa Cruz Biotechnology, andTh1 clones (Hannier et al., 2002). The latter finding is
an anti-phospho-ZAP-70 (Tyr-319) polyclonal antibody was fromespecially consistent with our putative model of a com-
Cell Signaling Technology. SLAT-specific antisera were preparedpetition between (nonproductive) SLAT and (productive)
by immunizing two rabbits with a bacterial GST-SLAT fusion protein.
phospho- for binding ZAP-70. Last, selective blocking
of Lck function, which prevents ZAP-70 recruitment to
Cell Culture, Stimulation, and Transfectionthe TCR and its activation, also induced Th2 skewing
Mouse lymph node and spleen cells were passed through a T cell(al-Ramadi et al., 1996). Together, these findings support
enrichment column (R&D Systems). CD4 T cells were enriched by
the notion that ZAP-70 function is more critical for Th1 negative selection using a magnetic activated cell sorting (MACS)
differentiation and cytokine production. However, we system with rat anti-mouse CD8 and B220 antibodies (Pharmingen)
cannot rule out a potential, similar role for Syk, which followed by incubation with goat anti-rat Ig-coated magnetic beads
(Miltenyi Biotech). Residual APCs and in vivo-activated T cells wereis expressed at low levels in primary T cells. This mecha-
removed by centrifugation through a Percol (Sigma) step gradientnism for the selective role of SLAT in Th development
of 45%, 53%, 62%, and 80%. Over 95% of the resulting cells dis-is consistent with observations that changes in overall
played a CD62L, CD44low phenotype characteristic of naive CD4
TCR affinity or signaling strength can significantly affect T cells. Cells were cultured in 24-well plates (2.5 
 105 cells/well)
Th1/Th2 differentiation and the resulting cytokine secre- in a total volume of 2 ml and stimulated with 0.3 M PCC peptide
tion profile (Constant and Bottomly, 1997). In many plus irradiated (3000 rad) B10.A spleen cells (5 
 106/well) as APCs
in the presence of 10 U/ml recombinant IL-12 and 10 g/ml anti-(Blander et al., 2000; Constant et al., 1995; Hosken et
IL-4 antibody to promote Th1 development, or in the presence ofal., 1995; Kumar et al., 1995) but not all (Pearson et
100 U/ml recombinant IL-4 and 10 g/ml anti-IL-12 antibody toal., 1997) instances, induction of Th2 cells has been
promote Th2 differentiation. In some experiments, the cells wereassociated with a weaker TCR-activating signal, as ap-
cultured in the presence of piceatannol (2.5 g/ml).
pears to be the case with regard to SLAT. Differentiated Th1 and Th2 cells (1 
 106/well) were restimulated
Another potential mechanism that could account for on day 7 with 0.3 M PCC peptide plus irradiated B10.A spleen
the observed effects of SLAT is implicated by the homol- cells (3 
 106/well) in the absence or presence of neutralizing anti-
IL-4 (10 g/ml), anti-IL-12 (10 g/ml), and anti-IFN (10 g/ml) anti-ogy between SLAT and SWAP-70. SWAP-70 expression
bodies in 24-well plates.increases after stimulation, and it undergoes nuclear
Human leukemic Jurkat T cells and simian virus 40 large T antigen-translocation, which correlates with the onset of Ig class
transfected Jurkat (Jurkat-TAg) cells were cultured and transfectedswitch in B cells (Borggrefe et al., 1999; Masat et al.,
as described (Villalba et al., 2000). After 48 hr, cells were collected,
2000). Consistent with this function, SWAP-70-deficient resuspended (2 
 107 cells/ml) in 0.5 ml of medium, and treated
mice display impaired IgE responses (Borggrefe et al., with PMA (100 ng/ml) plus ionomycin (1 g/ml), or anti-CD3 (OKT3)
2001). Later findings that SWAP-70 translocates to the antibody (2 g/ml) crosslinked with a secondary goat anti-mouse
IgG (5 g/ml) for 5 min at 37C.plasma membrane and associates with membrane IgG
early after BCR stimulation (Masat et al., 2000) sug-
gested that SWAP-70 may have an additional role in Confocal and FACS Analysis
proximal BCR signaling pathways. Surprisingly, how- These procedures were performed as described (Bi et al., 2001). In
ever, a recent study reported that the putative ERM brief, paraformaldehyde-fixed and permeabilized cells were stained
with primary antibodies. After washing, samples were incubateddomain of SWAP-70 is, in fact, a weakly conserved Dbl-
with Alexa594-coupled secondary antibody, washed, and mountedhomology (DH) domain, which activates Rac in vitro and
on glass slides. For antigen-specific stimulation, agonist (PCC 88-in vivo in fibroblasts (Shinohara et al., 2002). Studies to
104) or antagonist (T102G) (Huang et al., 2000) PCC peptide-pulsed
determine whether SLAT also possesses guanine nucle- APCs were settled on poly(L)lysine-coated glass slides. Differenti-
otide exchange activity are in progress. In this regard, ated Th2 cells were cultured on the slides for 30 min, fixed, perme-
a precedent exists for a differential role of Rac in Th1 abilized, and stained with TCR-, talin-, and/or SLAT-specific anti-
bodies plus Alexa488- and Alexa594-coupled secondary antibodies (Biversus Th2 differentiation (Li et al., 2000).
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et al., 2001). Imaging was done using a Bio-Rad MRC 1024 laser CAGCTGTATAGGG (5) and AGCGGCTGACTGAACTCAGATTGTAG
(3); -actin, TAAAACGCAGCTCAGTAACAGTCCG (5) and TGGscanning confocal imaging system.
AATCCTGTGGCATCCATGAAAC (3). Ten micrograms of each PCR
product was separated on 1.2% agarose/6% formaldehyde gels,Subcellular Fractionation, Immunoprecipitation,
transferred onto nylon membrane in SSC overnight, and covalentlyand Immunoblotting
bound using a UV crosslinker. Northern blots were performed ac-Jurkat cells were lysed as described (Villalba et al., 2000). For anti-
cording to standard protocols and hybridized with radiolabeledgen-specific stimulation, in vitro-differentiated Th2 cells from AD10
SLAT or G3PDH cDNA probes.TCR-transgenic mice were stimulated with PCC peptide-pulsed or
nonpulsed CH27 lymphoma cells as APCs for 30 min at 37C. Cells
were lysed in 300 l lysis buffer (20 mM Tris-HCl [pH 7.4], 2 mM Retroviral Constructs and Transduction
MgCl2, 0.1 mM EDTA, 100 mM (NH4)2SO4, 30 mM -glycerol phos- The SLAT cDNA was subcloned into the EcoRI site of the retroviral
phate, 1 mM Na3VO4, 0.75% Brij 58, and 10 g/ml each aprotinin vector pMIG. Platinum-E packaging cells (Morita et al., 2000) (.75 

and leupeptin) for 20 min on ice. Insoluble materials were removed 106 ) were plated on 60 mm dishes in 3 ml DMEM with 10% FBS.
by centrifugation at 16,000
 g (15 min at 4C). Subcellular fraction- Following overnight incubation, the cells were transfected with 3
ation and immunoprecipitation were performed as reported pre- g retroviral plasmid DNA using FuGENE 6 transfection reagent
viously (Villalba et al., 2000). Following transfer to nitrocellulose (Roche). After 20 hr, the medium was replaced with DMEM plus
membranes, the membranes were analyzed by immunoblotting. 10% FBS. Cultures were maintained for 24 hr, the retroviral superna-
Blots were developed using an enhanced chemiluminescence (ECL) tant was harvested, supplemented with 5g/ml polybrene, and used
kit (Amersham), and signals were analyzed using the public domain to infect CD4 T cells that had been preactivated with anti-CD3,
NIH Image program. anti-CD28, and 100 U/ml recombinant IL-2 for 18 hr. Plates were
centrifuged for 1 hr (2000 rpm, 33C) and incubated for 8 hr at 33C
and for 16 hr at 37C, followed by two additional retroviral infectionsLuciferase Reporter Assay
at daily intervals. The medium was exchanged with RPMI-1640 me-The Luc reporter gene driven by the human IFN promoter (	346
dium supplemented with 10% FBS plus 20 U/ml recombinant IL-2.to 7) (Kaminuma et al., 2002) and the IL-4-Luc construct (	270
to 	12) (Pesch et al., 1996) was described. Jurkat-TAg cells were
transfected with combinations of reporter plasmids (4g), a normal- Acknowledgments
ization control -galactosidase (-Gal) reporter plasmid (2 g), and
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